Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …

Abstract (See the editorial commentary by Holland and Fowler Jr, on pages 329–31.)
Background. There are concerns about reduced efficacy of vancomycin in patients with …

Objectives New therapies for complicated skin and skin structure infections (cSSSIs) are
needed because of significant morbidity and increasing antimicrobial resistance. Methicillin …

Background Findings from previous studies have suggested that outcomes after meticillin-
resistant Staphylococcus aureus (MRSA) bacteraemia are worse than after meticillin …

To determine the impact of infectious diseases consultation (IDC) in Staphylococcus aureus
bacteraemia. All MRSA bacteraemia and a random subset of MSSA bacteraemia were …

SAB remains a serious, potentially lethal infection, which is too often nosocomial and
healthcare-associated. A threat has been the increasing drug resistance of S. aureus seen …

Objectives We performed a systematic review and meta-analysis to estimate the effect of
early active empirical antibiotics for MRSA on mortality, both in patients admitted with MRSA …

Background Vancomycin therapeutic drug monitoring (TDM) is based on achieving 24-h
area under the concentration–time curve to minimum inhibitory concentration cure …

Background Hospital associated infections are major problems, which are increasing in
incidence and very costly. However, most research has focused only on measuring …